CervoMed Inc.
CRVO | NASDAQ
$2.44
+$0.03 (+1.24%)
Sep 22, 2026, 9:37 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 103.17K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -103.17K |
Operating Income | -28.29M | -18.23M | -7.81M | -3.48M | -24.68M | -15.98M |
Interest Income | 1.34M | 1.94M | 219.43K | 62.23K | 137.49K | 114.26K |
Pretax Income | -26.97M | -16.29M | -2.17M | -5.8M | -24.54M | -15.86M |
Net Income | -26.97M | -16.29M | -2.17M | -5.8M | -24.1M | -14.19M |
Selling & General & Admin | 10.48M | 9.17M | 6.52M | 2.14M | 7.45M | 6.44M |
Research & Development | 21.82M | 18.8M | 8.44M | 1.34M | 8.5M | 9.43M |
Other Expenses | -4.01M | -9.74M | -7.14M | n/a | 8.73M | n/a |
Operating Expenses | 28.29M | 18.23M | 7.81M | 3.48M | 24.68M | 15.87M |
Interest Expense | n/a | n/a | n/a | 587 | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.29M | 18.23M | 7.81M | 3.48M | 24.68M | 15.98M |
Income Tax Expense | n/a | n/a | n/a | n/a | -443.89K | -1.68M |
Shares Outstanding (Basic) | 9.04M | 8.07M | 2.66M | 518.14K | 1.3M | 717.76K |
Shares Outstanding (Diluted) | 9.04M | 8.07M | 2.66M | 518.14K | 1.3M | 717.76K |
EPS (Basic) | -2.98 | -2.02 | -0.82 | -11.20 | -18.51 | -22.50 |
EPS (Diluted) | -2.98 | -2.02 | -0.82 | -11.20 | -18.51 | -22.50 |
EBITDA | -26.97M | -16.29M | -2.17M | -5.8M | -15.94M | -15.76M |
EBIT | -26.97M | -16.29M | -2.17M | -5.8M | -16.04M | -15.86M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 93.42K | 103.17K |
Add to Watchlist
Select watchlists to add or remove CRVO